Liquid chromatographic estimation of (S) - glycidyl butyrate in (R) - glycidyl butyrate

The present study was undertaken out of a commercial need for the synthesis of Linezolid with impurity limits within the specification. (R)-Glycidyl butyrate (RGB) is raw material for the synthesis of Linezolid drug substance. This RGB contains (S)-(+)-Glycidyl butyrate (SGB) and SGB appears in same...

Full description

Saved in:
Bibliographic Details
Published in:Journal of natural science, biology and medicine biology and medicine, 2011-07, Vol.2 (2), p.180-184
Main Authors: Khan, Mubeen Ahmad, Sinha, Sukumar, Khandekar, Nandkumar, Parashar, Vikas
Format: Article
Language:English
Subjects:
Accuracy
Chromatography
Ethanol
International conferences
Original
Pharmaceutical industry
Raw materials
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The present study was undertaken out of a commercial need for the synthesis of Linezolid with impurity limits within the specification. (R)-Glycidyl butyrate (RGB) is raw material for the synthesis of Linezolid drug substance. This RGB contains (S)-(+)-Glycidyl butyrate (SGB) and SGB appears in same concentration in the final Active Pharmaceutical Ingredient. So, a normal phase high-performance liquid chromatography (HPLC) method has been developed to determine the SGB level in the raw material. RGB and SGB were separated using an HPLC system equipped with quaternary gradient pumps on a Daicel chiralpak AD-H (250 × 4.6 mm) column with a mobile phase consisting 2.0 ml of ethanol in 1 000 ml of n-hexane. A 0.5 ml/minute flow rate and a 10 μl injection volume was used and the compounds were detected at 215 nm. Method validation parameters demonstrated the same to be reliable, reproducible, and accurate one. Thus, the present study may be used for regular quality control of RGB to improve commercial feasibility for the synthesis of Linezolid.
ISSN:0976-9668
2229-7707
DOI:10.4103/0976-9668.92331